Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01790568
Title Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications
Therapies

Methotrexate

Tacrolimus

Vorinostat

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Cancer Center Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field